Framingham Heart Study
Since our beginning in 1948, the Framingham Heart Study (FHS), under the direction of the National Heart, Lung, and Blood Institute (NHLBI), formerly known as the National Heart Institute, has been committed to identifying the common factors or characteristics that contribute to cardiovascular disease (CVD).
Goals
- To identify common factors or characteristics that contribute to cardiovascular disease (CVD).
- Monitor the development of heart disease and stroke in a large cohort over time.
- Provide insights into the genetic and lifestyle risk factors of CVD.
Sponsor
- Federal Agency: National Heart, Lung, and Blood Institute (NHLBI)
- Sponsoring Office: Part of the National Institutes of Health
Creation
The Framingham Heart Study was launched in 1948 by the U.S. Public Health Service to investigate the epidemiology of cardiovascular disease. It was one of the first major epidemiological studies to focus on the causes of heart disease.
Funding
The study has been continuously funded by the National Heart, Lung, and Blood Institute since its inception. There's no specified end to the funding as it's an ongoing research project.
Leadership
The principal investigators of the Framingham Heart Study change over time. Currently, the study is led by the Director of the Framingham Heart Study at Boston University.
Website
https://www.framinghamheartstudy.org/
Social Media Accounts
- X (formerly Twitter): @FraminghamStudy
Wikipedia Article
wikipedia:Framingham Heart Study